Inogen, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $155.4M
- Price
- $5.86
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.60%
- Volume
- 82.7K
About
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Quick stats
Shares outstanding26.5M
Computed float23.1M
Float / shares87.0%
Cash runway (months)199.6
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001294133
Websitehttps://www.inogen.com
AI Summary
AI-generated1/19
majorbullishm and a
Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech
Inogen signed a definitive agreement to divest its U.S. oxygen rental business to Rotech Healthcare for estimated cash consideration of up to $25 million, expected to close in Q4 2026.
The Rental Business generated $24.3 million of revenue in H1 2026, down 9.8% year-over-year; Inogen will present it as discontinued operations beginning with Q3 2026 results and expects the deal to raise revenue growth and adjusted operating income.
Inogen also signed a long-term supply agreement with Rotech, and its board approved a $15 million buyback authorization increase (to $45 million total), contingent on the transaction closing.
Red flags
- divested rental business revenue was declining 9.8% YoY
- buyback increase contingent on transaction closing
- closing subject to customary conditions; timing and net proceeds not guaranteed